Is lanadelumab known to be excreted in human breast milk?

It is unknown whether lanadelumab is excreted in human breast milk; human IgGs enter milk during the first few days after birth, then decline to low concentrations, so risk to the breast-fed child cannot be excluded during this early period, but afterwards lanadelumab may be used if clinically needed.